Multivariate prognostic analysis showed that age, tumor site, WHO grade, recurrence, Ki-67 expression, IDH1 mutant, ATRX, ASAP3, and NOTCH3 expression were shown to be independent predictive determinants of overall survival in gliomas. The gene discussed is IDH1; the disease is central nervous system cancer.